147 related articles for article (PubMed ID: 22154831)
1. A pharmacological investigation of the venom extract of the Australian box jellyfish, Chironex fleckeri, in cardiac and vascular tissues.
Hughes RJ; Angus JA; Winkel KD; Wright CE
Toxicol Lett; 2012 Feb; 209(1):11-20. PubMed ID: 22154831
[TBL] [Abstract][Full Text] [Related]
2. The pharmacology of Malo maxima jellyfish venom extract in isolated cardiovascular tissues: A probable cause of the Irukandji syndrome in Western Australia.
Li R; Wright CE; Winkel KD; Gershwin LA; Angus JA
Toxicol Lett; 2011 Mar; 201(3):221-9. PubMed ID: 21237252
[TBL] [Abstract][Full Text] [Related]
3. Cardiovascular actions of the venom from the Irukandji (Carukia barnesi) jellyfish: effects in human, rat and guinea-pig tissues in vitro and in pigs in vitro.
Winkel KD; Tibballs J; Molenaar P; Lambert G; Coles P; Ross-Smith M; Wiltshire C; Fenner PJ; Gershwin LA; Hawdon GM; Wright CE; Angus JA
Clin Exp Pharmacol Physiol; 2005 Sep; 32(9):777-88. PubMed ID: 16173936
[TBL] [Abstract][Full Text] [Related]
4. The in vivo cardiovascular effects of box jellyfish Chironex fleckeri venom in rats: efficacy of pre-treatment with antivenom, verapamil and magnesium sulphate.
Ramasamy S; Isbister GK; Seymour JE; Hodgson WC
Toxicon; 2004 May; 43(6):685-90. PubMed ID: 15109889
[TBL] [Abstract][Full Text] [Related]
5. The in vitro vascular effects of two chirodropid (Chironex fleckeri and Chiropsella bronzie) venoms.
Winter KL; Fernando R; Ramasamy S; Seymour JE; Isbister GK; Hodgson WC
Toxicol Lett; 2007 Jan; 168(1):13-20. PubMed ID: 17141433
[TBL] [Abstract][Full Text] [Related]
6. A cell-based assay for screening of antidotes to, and antivenom against Chironex fleckeri (box jellyfish) venom.
Konstantakopoulos N; Isbister GK; Seymour JE; Hodgson WC
J Pharmacol Toxicol Methods; 2009; 59(3):166-70. PubMed ID: 19254771
[TBL] [Abstract][Full Text] [Related]
7. An in vivo comparison of the efficacy of CSL box jellyfish antivenom with antibodies raised against nematocyst-derived Chironex fleckeri venom.
Winter KL; Isbister GK; Jacoby T; Seymour JE; Hodgson WC
Toxicol Lett; 2009 Jun; 187(2):94-8. PubMed ID: 19429250
[TBL] [Abstract][Full Text] [Related]
8. An in vivo examination of the stability of venom from the Australian box jellyfish Chironex fleckeri.
Winter KL; Isbister GK; Seymour JE; Hodgson WC
Toxicon; 2007 May; 49(6):804-9. PubMed ID: 17215014
[TBL] [Abstract][Full Text] [Related]
9. An examination of the cardiovascular effects of an 'Irukandji' jellyfish, Alatina nr mordens.
Winter KL; Isbister GK; Schneider JJ; Konstantakopoulos N; Seymour JE; Hodgson WC
Toxicol Lett; 2008 Jul; 179(3):118-23. PubMed ID: 18547753
[TBL] [Abstract][Full Text] [Related]
10. The in vitro effects of two chirodropid (Chironex fleckeri and Chiropsalmus sp.) venoms: efficacy of box jellyfish antivenom.
Ramasamy S; Isbister GK; Seymour JE; Hodgson WC
Toxicon; 2003 May; 41(6):703-11. PubMed ID: 12727274
[TBL] [Abstract][Full Text] [Related]
11. The in vivo cardiovascular effects of an Australasian box jellyfish (Chiropsalmus sp.) venom in rats.
Ramasamy S; Isbister GK; Seymour JE; Hodgson WC
Toxicon; 2005 Mar; 45(3):321-7. PubMed ID: 15683870
[TBL] [Abstract][Full Text] [Related]
12. The effects of antivenom and verapamil on the haemodynamic actions of Chironex fleckeri (box jellyfish) venom.
Tibballs J; Williams D; Sutherland SK
Anaesth Intensive Care; 1998 Feb; 26(1):40-5. PubMed ID: 9513666
[TBL] [Abstract][Full Text] [Related]
13. Pharmacologically distinct cardiovascular effects of box jellyfish (Chironex fleckeri) venom and a tentacle-only extract in rats.
Ramasamy S; Isbister GK; Seymour JE; Hodgson WC
Toxicol Lett; 2005 Feb; 155(2):219-26. PubMed ID: 15603916
[TBL] [Abstract][Full Text] [Related]
14. Partial purification of cytolytic venom proteins from the box jellyfish, Chironex fleckeri.
Brinkman D; Burnell J
Toxicon; 2008 Apr; 51(5):853-63. PubMed ID: 18243272
[TBL] [Abstract][Full Text] [Related]
15. Cardiotoxic effects of venom fractions from the Australian box jellyfish Chironex fleckeri on human myocardiocytes.
Saggiomo SL; Seymour JE
Toxicon; 2012 Sep; 60(3):391-5. PubMed ID: 22560886
[TBL] [Abstract][Full Text] [Related]
16. A pharmacological and biochemical examination of the geographical variation of Chironex fleckeri venom.
Winter KL; Isbister GK; McGowan S; Konstantakopoulos N; Seymour JE; Hodgson WC
Toxicol Lett; 2010 Feb; 192(3):419-24. PubMed ID: 19945518
[TBL] [Abstract][Full Text] [Related]
17. Rapid short term and gradual permanent cardiotoxic effects of vertebrate toxins from Chironex fleckeri (Australian box jellyfish) venom.
Chaousis S; Smout M; Wilson D; Loukas A; Mulvenna J; Seymour J
Toxicon; 2014 Mar; 80():17-26. PubMed ID: 24462661
[TBL] [Abstract][Full Text] [Related]
18. The effectiveness of antivenom in countering the actions of box-jellyfish (Chironex fleckeri) nematocyst toxins in mice.
Endean R; Sizemore DJ
Toxicon; 1988; 26(5):425-31. PubMed ID: 2903586
[TBL] [Abstract][Full Text] [Related]
19. Identification, cloning and sequencing of two major venom proteins from the box jellyfish, Chironex fleckeri.
Brinkman D; Burnell J
Toxicon; 2007 Nov; 50(6):850-60. PubMed ID: 17688901
[TBL] [Abstract][Full Text] [Related]
20. Evidence for adrenergic and tachykinin activity in venom of the stonefish (Synanceja trachynis).
Hopkins BJ; Hodgson WC; Sutherland SK
Toxicon; 1996 May; 34(5):541-54. PubMed ID: 8783449
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
